BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

242 related articles for article (PubMed ID: 26787850)

  • 1. Transition state for the NSD2-catalyzed methylation of histone H3 lysine 36.
    Poulin MB; Schneck JL; Matico RE; McDevitt PJ; Huddleston MJ; Hou W; Johnson NW; Thrall SH; Meek TD; Schramm VL
    Proc Natl Acad Sci U S A; 2016 Feb; 113(5):1197-201. PubMed ID: 26787850
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Nucleosome Binding Alters the Substrate Bonding Environment of Histone H3 Lysine 36 Methyltransferase NSD2.
    Poulin MB; Schneck JL; Matico RE; Hou W; McDevitt PJ; Holbert M; Schramm VL
    J Am Chem Soc; 2016 Jun; 138(21):6699-702. PubMed ID: 27183271
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro histone lysine methylation by NSD1, NSD2/MMSET/WHSC1 and NSD3/WHSC1L.
    Morishita M; Mevius D; di Luccio E
    BMC Struct Biol; 2014 Dec; 14():25. PubMed ID: 25494638
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Structural basis of the regulation of the normal and oncogenic methylation of nucleosomal histone H3 Lys36 by NSD2.
    Sato K; Kumar A; Hamada K; Okada C; Oguni A; Machiyama A; Sakuraba S; Nishizawa T; Nureki O; Kono H; Ogata K; Sengoku T
    Nat Commun; 2021 Nov; 12(1):6605. PubMed ID: 34782608
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular basis of nucleosomal H3K36 methylation by NSD methyltransferases.
    Li W; Tian W; Yuan G; Deng P; Sengupta D; Cheng Z; Cao Y; Ren J; Qin Y; Zhou Y; Jia Y; Gozani O; Patel DJ; Wang Z
    Nature; 2021 Feb; 590(7846):498-503. PubMed ID: 33361816
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NSD2 links dimethylation of histone H3 at lysine 36 to oncogenic programming.
    Kuo AJ; Cheung P; Chen K; Zee BM; Kioi M; Lauring J; Xi Y; Park BH; Shi X; Garcia BA; Li W; Gozani O
    Mol Cell; 2011 Nov; 44(4):609-20. PubMed ID: 22099308
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A PWWP Domain of Histone-Lysine N-Methyltransferase NSD2 Binds to Dimethylated Lys-36 of Histone H3 and Regulates NSD2 Function at Chromatin.
    Sankaran SM; Wilkinson AW; Elias JE; Gozani O
    J Biol Chem; 2016 Apr; 291(16):8465-74. PubMed ID: 26912663
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Kinetic isotope effects reveal early transition state of protein lysine methyltransferase SET8.
    Linscott JA; Kapilashrami K; Wang Z; Senevirathne C; Bothwell IR; Blum G; Luo M
    Proc Natl Acad Sci U S A; 2016 Dec; 113(52):E8369-E8378. PubMed ID: 27940912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Product specificity and mechanism of protein lysine methyltransferases: insights from the histone lysine methyltransferase SET8.
    Zhang X; Bruice TC
    Biochemistry; 2008 Jun; 47(25):6671-7. PubMed ID: 18512960
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Catalytic properties and kinetic mechanism of human recombinant Lys-9 histone H3 methyltransferase SUV39H1: participation of the chromodomain in enzymatic catalysis.
    Chin HG; Patnaik D; Estève PO; Jacobsen SE; Pradhan S
    Biochemistry; 2006 Mar; 45(10):3272-84. PubMed ID: 16519522
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Total kinetic analysis reveals how combinatorial methylation patterns are established on lysines 27 and 36 of histone H3.
    Zheng Y; Sweet SM; Popovic R; Martinez-Garcia E; Tipton JD; Thomas PM; Licht JD; Kelleher NL
    Proc Natl Acad Sci U S A; 2012 Aug; 109(34):13549-54. PubMed ID: 22869745
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Scalable Platform for Producing Recombinant Nucleosomes with Codified Histone Methyltransferase Substrate Preferences.
    McDevitt PJ; Schneck JL; Diaz E; Hou W; Huddleston MJ; Matico RE; McCormick PM; Kirkpatrick RB
    Protein Expr Purif; 2019 Dec; 164():105455. PubMed ID: 31306746
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A chemical probe targeting the PWWP domain alters NSD2 nucleolar localization.
    Dilworth D; Hanley RP; Ferreira de Freitas R; Allali-Hassani A; Zhou M; Mehta N; Marunde MR; Ackloo S; Carvalho Machado RA; Khalili Yazdi A; Owens DDG; Vu V; Nie DY; Alqazzaz M; Marcon E; Li F; Chau I; Bolotokova A; Qin S; Lei M; Liu Y; Szewczyk MM; Dong A; Kazemzadeh S; Abramyan T; Popova IK; Hall NW; Meiners MJ; Cheek MA; Gibson E; Kireev D; Greenblatt JF; Keogh MC; Min J; Brown PJ; Vedadi M; Arrowsmith CH; Barsyte-Lovejoy D; James LI; Schapira M
    Nat Chem Biol; 2022 Jan; 18(1):56-63. PubMed ID: 34782742
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Substrate-Differentiated Transition States of SET7/9-Catalyzed Lysine Methylation.
    Chen S; Kapilashrami K; Senevirathne C; Wang Z; Wang J; Linscott JA; Luo M
    J Am Chem Soc; 2019 May; 141(20):8064-8067. PubMed ID: 31034218
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An activating mutation of the NSD2 histone methyltransferase drives oncogenic reprogramming in acute lymphocytic leukemia.
    Swaroop A; Oyer JA; Will CM; Huang X; Yu W; Troche C; Bulic M; Durham BH; Wen QJ; Crispino JD; MacKerell AD; Bennett RL; Kelleher NL; Licht JD
    Oncogene; 2019 Jan; 38(5):671-686. PubMed ID: 30171259
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Functional characterization of the zebrafish WHSC1-related gene, a homolog of human NSD2.
    Yamada-Okabe T; Imamura K; Kawaguchi N; Sakai H; Yamashita M; Matsumoto N
    Biochem Biophys Res Commun; 2010 Nov; 402(2):335-9. PubMed ID: 20946879
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substrate specificity and kinetic mechanism of mammalian G9a histone H3 methyltransferase.
    Patnaik D; Chin HG; Estève PO; Benner J; Jacobsen SE; Pradhan S
    J Biol Chem; 2004 Dec; 279(51):53248-58. PubMed ID: 15485804
    [TBL] [Abstract][Full Text] [Related]  

  • 18. 5-Aminonaphthalene derivatives as selective nonnucleoside nuclear receptor binding SET domain-protein 2 (NSD2) inhibitors for the treatment of multiple myeloma.
    Wang S; Yang H; Su M; Lian F; Cong Z; Wei R; Zhou Y; Li X; Zheng X; Li C; Fu X; Han X; Shi Q; Li C; Zhang N; Geng M; Liu H; Li J; Huang X; Wang J
    Eur J Med Chem; 2021 Oct; 222():113592. PubMed ID: 34147909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Distinct kinetic mechanisms of H3K4 methylation catalyzed by MLL3 and MLL4 core complexes.
    Zheng Y; Huang Y; Mencius J; Li Y; Zhao L; Luo W; Chen Y; Quan S
    J Biol Chem; 2021; 296():100635. PubMed ID: 33823156
    [TBL] [Abstract][Full Text] [Related]  

  • 20. NSD2 as a Promising Target in Hematological Disorders.
    Azagra A; Cobaleda C
    Int J Mol Sci; 2022 Sep; 23(19):. PubMed ID: 36232375
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.